Search

Your search keyword '"Azman, Andrew"' showing total 768 results

Search Constraints

Start Over You searched for: Author "Azman, Andrew" Remove constraint Author: "Azman, Andrew"
768 results on '"Azman, Andrew"'

Search Results

1. Spatiotemporal Modeling of Cholera, Uvira, Democratic Republic of the Congo, 2016-2020

5. Author Correction: Clinical surveillance systems obscure the true cholera infection burden in an endemic region

6. Seroincidence of Enteric Fever, Juba, South Sudan - Volume 28, Number 11—November 2022 - Emerging Infectious Diseases journal - CDC

7. Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts' meeting on serum biomarkers.

8. Population-Based Serologic Survey of Vibrio cholerae Antibody Titers before Cholera Outbreak, Haiti, 2022

9. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study

10. Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study

12. Socioeconomic conditions and children's mental health and quality of life during the COVID-19 pandemic: An intersectional analysis

13. Protocol to implement a syndromic surveillance survey of COVID-19 in Malawi

16. Covid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout: a cross-sectional analysis of a cohort study.

17. Geospatial distribution of Hepatitis E seroprevalence in Nepal, 2021.

18. Estimating the proportion of clinically suspected cholera cases that are true Vibrio cholerae infections: A systematic review and meta-analysis

19. SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan

20. Cholera

23. The importance of thinking beyond the water-supply in cholera epidemics: A historical urban case-study.

24. High Hepatitis E Seroprevalence Among Displaced Persons in South Sudan

28. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020

29. Challenges and Approaches to Establishing Multi-Pathogen Serosurveillance: Findings from the 2023 Serosurveillance Summit.

30. Analysis of Cholera Risk in India: Insights from 2017–18 Serosurvey Data Integrated with Epidemiologic data and Societal Determinants from 2015–2019.

33. Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17

35. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

36. NewVibrio choleraesequences from Eastern and Southern Africa alter our understanding of regional cholera transmission

37. Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection

39. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis

41. SARS-CoV-2 Seroprevalence before Delta Variant Surge, Chattogram, Bangladesh, March--June 2021

42. Correction: Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, Kenya

43. Cholera deaths during outbreaks in Uvira, eastern Democratic Republic of the Congo, 10-35 months after mass vaccination

44. Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan

45. Challenges with Achieving and Maintaining High Oral Cholera Vaccine Coverage in Uvira, The Democratic Republic of the Congo: serial cross-sectional representative surveys

46. Annual risk of hepatitis E virus infection and seroreversion: Insights from a serological cohort in Sitakunda, Bangladesh

47. Improved water supply infrastructure to reduce acute diarrhoeal diseases and cholera in Uvira, Democratic Republic of the Congo: Results and lessons learned from a pragmatic trial.

Catalog

Books, media, physical & digital resources